Very high doses of CBD, a cannabis component, don't affect driving

Written By :  Dr. Kamal Kant Kohli
Published On 2022-06-24 01:00 GMT   |   Update On 2022-06-24 06:28 GMT
Advertisement

Millions of consumers and patients around the world will be heartened by the results of the latest study on cannabis and driving. The University of Sydney-led research finds that 1500mg, the highest daily medicinal dose of cannabidiol (CBD), has no impact on people's driving or cognitive abilities.

CBD is a cannabis component widely used for medical as well as 'wellness' purposes, such as to induce sleep or boost energy. It is often consumed orally, in oil form.

Most countries, including Australia, allow people to drive while on CBD. In NSW, for example, it is legal provided a driver is not 'impaired' due to fatigue and/or lowered blood pressure. The present study shows, contraindications aside, that even at the highest medicinal dose of 1500mg, CBD does not cause impairment.

"Though CBD is generally considered 'non-intoxicating', its effects on safety-sensitive tasks are still being established," said lead author Dr Danielle McCartney, from the University's Lambert Initiative for Cannabinoid Therapeutics. "Our study is the first to confirm that, when consumed on its own, CBD is driver-safe."

Unlike THC, a cannabis component that can induce sedation, euphoria (a 'high') and impairment, CBD does not appear to intoxicate people. Instead, it has been reported to have calming and pain relief effects.

Peak concentrations of CBD in a person's blood plasma are usually attained within three to four hours after taking it orally, although individual responses vary.

CBD use is increasing in Western nations, with recent University of Sydney research showing that around 55,000 requests to access medicinal CBD have been approved in Australia since 2016. It is most commonly prescribed for pain, sleep disorders and anxiety.

For further reference log on to:

http://dx.doi.org/10.1177/02698811221095356

Tags:    
Article Source : Journal of Psychopharmacology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News